Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer-Reference-Cited by-同舟云学术

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer

Published:2015-10-03 Issue:2 Volume:10 Page:213-223
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Alsubhi Nouf,Middleton Fiona,Abdel-Fatah Tarek M.A.,Stephens Peter,Doherty Rachel,Arora Arvind,Moseley Paul M.,Chan Stephen Y.T.,Aleskandarany Mohammed A.,Green Andrew R.,Rakha Emad A.,Ellis Ian O.,Martin Stewart G.,Curtin Nicola J.,Madhusudan Srinivasan

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference44 articles.

1. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts;Abdel-Fatah;Neoplasia,2014

2. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer;Abdel-Fatah;Mol. Oncol,2015

3. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy;Albarakati;Mol. Oncol,2015

4. Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast Cancer;Arora;Mol. Cancer Ther,2015

5. Chk1 and Chk2 kinases in checkpoint control and cancer;Bartek;Cancer Cell,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin reverses EGFR-TKI therapeutic resistance by modulating crosstalk between circadian-related gene signature and immune infiltration patterns in patients with COVID-19 and lung adenocarcinoma;Computers in Biology and Medicine;2024-09

2. Cancer stem cells—Challenges for cancer therapies;Cancer Epigenetics and Nanomedicine;2024

3. Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers;npj Breast Cancer;2023-03-30

4. Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition;The Journal of Pathology;2022-12-08

5. Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer;Cancer Innovation;2022-09-26